Maridea Wealth Management LLC Increases Stake in McKesson Corporation $MCK

Maridea Wealth Management LLC raised its position in McKesson Corporation (NYSE:MCK) by 597.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,777 shares of the company’s stock after acquiring an additional 2,379 shares during the period. Maridea Wealth Management LLC’s holdings in McKesson were worth $2,278,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. GGM Financials LLC purchased a new position in McKesson during the third quarter worth about $25,000. State of Wyoming purchased a new stake in McKesson in the 2nd quarter valued at approximately $29,000. Hopwood Financial Services Inc. purchased a new stake in McKesson in the 3rd quarter valued at approximately $31,000. Vermillion & White Wealth Management Group LLC acquired a new position in McKesson during the 3rd quarter worth approximately $33,000. Finally, Board of the Pension Protection Fund acquired a new position in McKesson during the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In related news, EVP Michele Lau sold 2,725 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president directly owned 3,247 shares in the company, valued at $3,214,530. The trade was a 45.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Maria Martinez sold 349 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the sale, the director directly owned 301 shares in the company, valued at approximately $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 3,868 shares of company stock valued at $3,743,820 in the last three months. 0.08% of the stock is owned by insiders.

Analyst Ratings Changes

MCK has been the subject of several recent analyst reports. Barclays raised their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Wells Fargo & Company upped their price objective on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Zacks Research cut McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Wall Street Zen raised McKesson from a “hold” rating to a “buy” rating in a report on Sunday. Finally, Robert W. Baird set a $968.00 target price on shares of McKesson in a research report on Wednesday, January 14th. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, McKesson has a consensus rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Price Performance

Shares of NYSE:MCK opened at $888.28 on Friday. The business’s 50 day simple moving average is $903.68 and its 200-day simple moving average is $833.49. The firm has a market capitalization of $108.81 billion, a price-to-earnings ratio of 25.55, a price-to-earnings-growth ratio of 1.43 and a beta of 0.38. McKesson Corporation has a 12 month low of $637.00 and a 12 month high of $999.00.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter in the prior year, the firm posted $8.03 EPS. The company’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.